March 14, 2023

Decibel Therapeutics

Decibel Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

March 13, 2023

Pliant Therapeutics

Pliant Therapeutics Announces Positive DSMB Safety Review and Initiation of Enrollment of Phase 2a Trial of Bexotegrast (PLN-74809) at 320 mg Dose in Primary Sclerosing Cholangitis

March 09, 2023

Fulcrum Therapeutics

Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for the Fourth Quarter and Full Year 2022

March 09, 2023

Abata Therapeutics

Abata Therapeutics Appoints David Kaufman, M.D., Ph.D., to its Board of Directors

March 08, 2023

Pliant Therapeutics

Pliant Therapeutics Announces Appointments of Darren Cline and Thomas McCourt to Board of Directors

Load More

Sign up for weekly portfolio news.